Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DUAL-ACTIVITY NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2018/085379
Kind Code:
A3
Abstract:
The present disclosure describes NAMPT modulatory compounds, and methods of identifying NAMPT modulatory compounds. The present disclosure also describes methods of testing NAMPT modulatory compounds for NTPase activity, cell mobility modulatory activity, and cell metastasis modulatory activity.

Inventors:
GARDELL STEPHEN (US)
DISPAGNA MAURO (US)
Application Number:
PCT/US2017/059508
Publication Date:
June 28, 2018
Filing Date:
November 01, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US)
International Classes:
A61K31/7084; G01N30/72
Domestic Patent References:
WO2012150952A12012-11-08
WO2013170191A12013-11-14
Other References:
BURGOS ET AL.: "Weak Coupling of ATP Hydrolysis to the Chemical Equilibrium of Human Nicotinamide Phosphoribosyltransferase", BIOCHEMISTRY, vol. 47, 30 September 2008 (2008-09-30), pages 11086 - 11096, XP055495736
BURGOS ET AL.: "A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT", PNAS, vol. 106, 18 August 2009 (2009-08-18), pages 13748 - 13753, XP055495738
AMICI ET AL.: "Synthesis and Degradation of Adenosine 5'-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases", CELL CHEMICAL BIOLOGY, vol. 24, 18 May 2017 (2017-05-18), pages 553 - 564, XP055495739
Attorney, Agent or Firm:
AMODEO, Gabriele, A. et al. (US)
Download PDF: